Vistusertib

TargetMol
Product Code: TAR-T1961
Supplier: TargetMol
CodeSizePrice
TAR-T1961-2mg2mg£105.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1961-5mg5mg£125.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1961-1mL1 mL * 10 mM (in DMSO)£132.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1961-10mg10mg£166.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1961-25mg25mg£218.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1961-50mg50mg£270.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1961-100mg100mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
AZD2014 is an orally bioavailable inhibitor of the mammalian target of rapamycin (mTOR) with potential antineoplastic activity.
CAS:
1009298-59-2
Formula:
C25H30N6O3
Molecular Weight:
462.554
Pathway:
Apoptosis; MAPK; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Autophagy
Purity:
0.9794
SMILES:
CNC(=O)c1cccc(c1)-c1ccc2c(nc(nc2n1)N1CCOC[C@@H]1C)N1CCOC[C@@H]1C
Target:
Apoptosis; Akt; PI3K; S6 Kinase; mTOR; Autophagy

References

1. Sylvie M, et al, AACR Annual Meeting, 2012, Abst 917. 2. Guichard SM, et al. Mol Cancer Ther. 2015, 14(11):2508-18.